Cancer Diagnostics – Products

MoFlo® Astrios EQ from Beckman Coulter Life Sciences Delivers Simultaneous High-speed Cell Sorting and Sub-micron Particle Detection.

New kits enable mutation detection from circulating tumor cells using next-generation sequencing.

Introduced less than three years ago, ddPCR is rapidly gaining acceptance within the cancer research community. In fact, from 2012 to 2013, the number of cancer research papers involving ddPCR has nearly quintupled.

Expansion to identify novel biomarkers predictive of cancer outcomes.

First-in-class CLIA assay for detection of tumor-specific gene amplifications using circulating cell-free DNA.

PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

Addition of New Jenner-Wright Giemsa stain to Company’s Dako Artisan™ Link portfolio.

Study results published in New England Journal of Medicine show the verifi® prenatal test achieves positive predictive value tenfold higher than current standard of care.

PicoPLEX™ single-cell library preparation kits for IVF and other applications now available for sequencing on Illumina platforms.

EKF Diagnostics’ subsidiary company is exhibiting its ground-breaking technology at Tri-Con 2014 in San Francisco, CA, Booth #417, 10-14th February.